NCT00364832View on ClinicalTrials.gov

A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.

PHASE2CompletedINTERVENTIONAL

Enrollment

137

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions

Anemia

Interventions

DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

Differing doses and frequencies of sc administration

Trial Locations (23)

10625

Berlin

20122

Milan

23900

Lecco

24128

Bergamo

26506

Morgantown

26900

Lodi

27100

Pavia

28007

Madrid

28046

Madrid

29010

Málaga

36100

Vicenza

39008

Santander

41100

Modena

44106

Cleveland

68167

Mannheim

69168

Wiesloch

70124

Bari

77030

Houston

78054

Villingen-Schwenningen

90073

Los Angeles

95116-1906

San Jose

02130

Boston

08036

Barcelona

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00364832 - A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia. | Biotech Hunter | Biotech Hunter